Desmoid Tumors News

Sandfly bites cause big trouble for newly married couple - STLtoday.com



Sandfly bites cause big trouble for newly married couple 
STLtoday.com
Indeed, any kind of tumor can press against nerves and cause pain. The pain from nerve damage usually is described as ?burning,? ?pins-and-needles? or ?sharp,? so the quality of pain can give a clue to its underlying source. Some tumors, such as ...

and more » 


SpringWorks Therapeutics Launches with $103M in Funding - Drug Discovery & Development



Drug Discovery & Development
 
SpringWorks Therapeutics Launches with $103M in Funding 
Drug Discovery & Development
A desmoid tumor is a rare, non-metastatic tumor of connective tissue cells, which can cause severe morbidity, pain and loss of function in children and adults. Desmoid tumors can show up in almost any part of the body, and desmoids that are faster ...

 


Pfizer Creates New Smaller Company to Focus on Rare Diseases - Rare Disease Report



Rare Disease Report
 
Pfizer Creates New Smaller Company to Focus on Rare Diseases 
Rare Disease Report
Desmoid tumors are a slow-growing, benign tumors that grow in connective tissue and affects 900 to 1,200 people each year. There is no approved therapy for these tumors and in most cases, the tumors are removed surgically. Usually, the tumors reappear ...
Pfizer spins off new company with four rare disease therapies Pharmaceutical Business Review
SpringWorks spins out of Pfizer on rare disease mission pharmaphorum
Pfizer spins out SpringWorks Therapeutics biotech PMLiVE

all 4 news articles » 


Pfizer Spins Off New Firm for Some Rare Disease Drugs - Bloomberg



Bloomberg
 
Pfizer Spins Off New Firm for Some Rare Disease Drugs 
Bloomberg
The drug is ready for a late-stage trial to treat desmoid tumors, a slow-growing, non-metastatic tumor that affects 900 to 1,200 people each year and has no approved therapy in the U.S. Pfizer ceased testing the pill in breast cancer but the National ...
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life Xconomy
SpringWorks Therapeutics Launches with $103M in Series A Funding and Rights to Four Clinical Programs Business Wire (press release)
Pfizer launches upstart with $103M, phase 3-ready drugs FierceBiotech
Endpoints News  -BioWorld Online  -PharmaLive (press release) 
all 15 news articles » 


Halloween celebrations and other events in and around Northwest Austin this weekend, Oct. 20-22 - Community Impact Newspaper



Community Impact Newspaper
 
Halloween celebrations and other events in and around Northwest Austin this weekend, Oct. 20-22 
Community Impact Newspaper
The Project Serve at The Domain hosts the Joe Strong Fundraising Tournament, a Halloween-themed four-person team volleyball tournament benefiting Desmoid tumor research. Participants are encouraged to wear Halloween costumes. 9 a.m. $35.

 


Michelle Rounds' Body Allegedly 'Surrounded By Pill Bottles' At ... - Hollywood Life



Hollywood Life
 


Did You Really Just Ask That? - Women's eNews



Women's eNews
 
Did You Really Just Ask That? 
Women's eNews
?Yeah?? I ask, figuring maybe, just maybe, it's about the tumble I took in the hallway before sixth hour yesterday. Hey, better yet, maybe it's about something that was in the yearbook! Those came out today, and I know there's a pretty cool picture of ...

 


Biotech VC Eyes Record Year after Strong Q3 - Genetic Engineering & Biotechnology News (blog)



Biotech VC Eyes Record Year after Strong Q3 
Genetic Engineering & Biotechnology News (blog)
Desmoid tumor, for which SpringWorks plans to launch a Phase III program for its gamma-secretase inhibitor nirogacestat (PF-03084014), in cooperation with the Desmoid Tumor Research Foundation. Neurofibromatosis (NF), for which the company plans to ...

 


Results of Focused Ultrasound Treatment of Osteoid Osteoma ... - Newswise (press release)



Results of Focused Ultrasound Treatment of Osteoid Osteoma ... 
Newswise (press release)
Karun Sharma, MD, PhD, Director of Interventional Radiology, and colleagues at Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National ...

and more » 


Axios Pro Rata - Axios



Axios
 
Axios Pro Rata 
Axios
The company is launching with four compounds licensed from Pfizer, including a pair ? one in desmoid tumor and another for hereditary xerocytosis ? that are ready for Phase 3 clinical trials. Pfizer also has some royalty rights via the transaction ...